Boundless Historical Income Statement
| BOLD Stock | USD 10.00 0.10 1.01% |
Historical analysis of Boundless Bio, income statement accounts such as Selling General Administrative of 11.5 M, Other Operating Expenses of 55.2 M or Research Development of 43.7 M can show how well Boundless Bio, Common performed in making a profits. Evaluating Boundless Bio, income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Boundless Bio,'s future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Boundless Bio, Common latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Boundless Bio, Common is a good buy for the upcoming year.
Boundless |
About Boundless Income Statement Analysis
Boundless Bio, Common Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Boundless Bio, shareholders. The income statement also shows Boundless investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Boundless Bio, Income Statement Chart
Boundless Bio, Common Income Statement is one of the three primary financial statements used for reporting Boundless's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Boundless Bio, Common revenue and expense. Boundless Bio, Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Boundless Bio,'s Research Development is projected to decrease significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 55.2 M, whereas Selling General Administrative is forecasted to decline to about 11.5 M. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Boundless Bio, Common. It is also known as Boundless Bio, overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Boundless Bio,'s income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Boundless Bio, Common current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boundless Bio, Common. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. At present, Boundless Bio,'s Research Development is projected to decrease significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 55.2 M, whereas Selling General Administrative is forecasted to decline to about 11.5 M.
| 2010 | 2022 | 2023 | 2024 (projected) | Interest Income | 96K | 668K | 5.3M | 5.5M | Net Interest Income | 96K | 668K | 5.3M | 5.5M |
Boundless Bio, income statement Correlations
Click cells to compare fundamentals
Boundless Bio, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Boundless Bio, income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 3.7M | 7.5M | 682K | 942K | 957K | 909.2K | |
| Selling General Administrative | 17.3M | 30.0M | 6.0M | 9.3M | 12.2M | 11.5M | |
| Other Operating Expenses | 93.2M | 134.4M | 25.3M | 46.5M | 54.8M | 55.2M | |
| Operating Income | (93.2M) | (134.4M) | (25.3M) | (46.5M) | (54.8M) | (57.5M) | |
| Ebit | (92.5M) | (128.8M) | (25.3M) | (46.5M) | (54.8M) | (57.5M) | |
| Research Development | 75.9M | 104.4M | 19.3M | 37.2M | 42.6M | 43.7M | |
| Ebitda | (88.7M) | (121.4M) | (24.6M) | (45.5M) | (53.8M) | (56.5M) | |
| Total Operating Expenses | 93.2M | 134.4M | 25.3M | 46.5M | 54.8M | 55.2M | |
| Income Before Tax | (92.5M) | (128.8M) | (25.2M) | (45.9M) | (49.4M) | (51.9M) | |
| Total Other Income Expense Net | 693K | 5.6M | (5K) | (100K) | 80K | 76K | |
| Net Income | (90.2M) | (128.8M) | (25.2M) | (45.9M) | (49.4M) | (51.9M) | |
| Income Tax Expense | (2.2M) | 5.6M | (96K) | (668K) | (5.3M) | (5.0M) |
Pair Trading with Boundless Bio,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boundless Bio, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will appreciate offsetting losses from the drop in the long position's value.Moving against Boundless Stock
| 0.47 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.45 | VCYT | Veracyte Financial Report 2nd of May 2024 | PairCorr |
| 0.44 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.44 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.42 | VCNX | Vaccinex | PairCorr |
The ability to find closely correlated positions to Boundless Bio, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boundless Bio, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boundless Bio, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boundless Bio, Common to buy it.
The correlation of Boundless Bio, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boundless Bio, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boundless Bio, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boundless Bio, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boundless Bio, Common. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Boundless Stock analysis
When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Boundless Bio,'s industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.33) | Return On Equity (0.53) |
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.